HK Movers | XtalPi Stock Jumps 5% as Its Subsidiary Ailux Partners with Lilly on AI-Driven Bispecific Antibody Development

Reuters
2025/11/06

XtalPi stock jumped over 5% on Thursday.

Shanghai Ailux Biotechnology Co., Ltd. (Ailux Shanghai), a wholly-owned subsidiary of XtalPi Holdings Ltd., has announced a strategic collaboration with Eli Lilly and Company to accelerate the discovery and development of AI-driven bispecific antibodies for the treatment of various diseases.

Ailux is the biologics innovation arm of XtalPi, specializing in advanced biotherapeutics with AI-powered solutions.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10